Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Dec 25, 2017 6:50pm
106 Views
Post# 27225654

RE:RE:RE:When will get news on how may patients have been treated?

RE:RE:RE:When will get news on how may patients have been treated?
macman1519 wrote:
Ur right Bbbeny, the CEO, should be the company and stock promoter!! Anybody see the sphinx anywhere, any speeches, interviews??? How about any personal appearances anywhere???? Nope we don't expect the hospital to do that, but we sure as hellllll expect the CEO to do that!!! Any possible reasons, rog has been in hibernation mode for last 10 months???? Anybody?? 


bencro wrote: CUNI23 ... Nothing to do with secrecy.  This has been planned like this, as PMH doesn't only have this to do and they couldn't care less that you own shares in a stock that is doing a trial @PMH.  Consider yourself lucky to have had info. on patients #2-#4.

You're dealing with top 3 oncology in the world.  Not a kindergarden type of organization.  Do you really think they care about a share price?  

All oncology trials involve companies listed on a stock exchange.  So should PMH change its focus and become a stock promoter???








As the fake bladder cancer detection company ime (not even in human trial stage), Its CEO even promoted its stock in BNN recently, why shouldn't RW do same thing to promote the company?why always concentrates on cheap pp things? As to seek JV is probably the best choice at the current stage , why not give a try , even just an easy PR for seeking JV would change a lots.
Bullboard Posts